ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,323.00
0.00%
S&P ASX All Technology
3,880.20
0.00%
Brent Oil
73.875
1.42%
US Dollar vs AUD
1.53547
-0.01%
Bitcoin
98,366.98
4.25%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Italy
  5. BIT

  6. Brembo NV (BRE) Share Price

Brembo NV

Brembo NV (BRE)

Brazilian Rare Earths Ltd
Bridgemarq Real Estate Services Inc
8.633
0.039
(0.45%)
Closed 22 November 3:30AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
8.633
Bid
8.515
Offer
8.66
Volume
278,103
8.519 Day's Range 8.649
8.519 52 Week Range 12.39
Market Cap
2.796B
Previous Close
8.594
Open
8.575
Last Trade
109
@
8.633
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
610,403
Shares Outstanding
323,887,250
Dividend Yield
3.48%
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
3.89B
Net Profit
305.04M

About Brembo NV

Sector
Motor Vehicle Part,accessory
Industry
Motor Vehicle Part,accessory
Website
www.brembo.com
Headquarters
Bergamo, Bergamo, Ita
Founded
-
Brembo NV is listed in the Motor Vehicle Part,accessory sector of the Italian Stock Exchange with ticker BRE. The last closing price for Brembo NV was 8.59 €. Over the last year, Brembo NV shares have traded in a share price range of 8.519 € to 12.39 €.

Brembo NV currently has 323,887,250 shares in issue. The market capitalisation of Brembo NV is 2.78 € billion.

Ask ADVFN Intelligence (AI)

BRE Latest News

More News

UPDATE: Italy's Brembo Sees Higher 2012 Sales;Sees Crisis Risks

Brembo SpA (BRE.MI), an Italian maker of specialty brakes, Thursday forecast sales to rise next year on the back of growing demand for premium cars, but one of its executives expressed concern...

11 November 2011
Dow Jones News

BRE Properties Confirms Third Quarter 2009 Earnings Release and Conference Call Schedule

SAN FRANCISCO, Oct. 6 /PRNewswire-FirstCall/ -- BRE Properties, Inc. (NYSE:BRE) today confirmed the following schedule for its third quarter 2009 earnings release and conference call: Dates...

07 October 2009
PR Newswire (US)

BRE Properties Appoints Stephanie T. Andre as Vice President, Treasurer

SAN FRANCISCO, Sept. 16 /PRNewswire-FirstCall/ -- BRE Properties, Inc. (NYSE:BRE) today announced the appointment of Stephanie T. Andre as vice president, treasurer, effective immediately. Andre...

17 September 2009
PR Newswire (US)

BRE Properties Reports Second Quarter 2009 Results

SAN FRANCISCO, Aug. 4 /PRNewswire-FirstCall/ -- BRE Properties, Inc. (NYSE:BRE) today reported operating results for the quarter ended June 30, 2009. All per share results are reported on a...

05 August 2009
PR Newswire (US)

BRE Properties Announces Second Quarter 2009 Conference Call Webcast.

SAN FRANCISCO, July 31 /PRNewswire-FirstCall/ -- BRE PROPERTIES, INC. (NYSE:BRE) announces the following Webcast: What: BRE Properties Second Quarter 2009 Conference Call When: Wednesday...

05 August 2009
PR Newswire (US)

BRE Properties Announces Second Quarter 2009 Conference Call Webcast.

SAN FRANCISCO, July 31 /PRNewswire-FirstCall/ -- BRE PROPERTIES, INC. (NYSE:BRE) announces the following Webcast: What: BRE Properties Second Quarter 2009 Conference Call When: Wednesday...

31 July 2009
PR Newswire (US)

BRE Properties Announces Reduction in Common Dividend

Third Quarter 2009 Common and Preferred Dividends Declared SAN FRANCISCO, July 30 /PRNewswire-FirstCall/ -- BRE Properties, Inc. (NYSE:BRE) today announced that its board of directors approved a...

31 July 2009
PR Newswire (US)

BRE Properties Confirms Second Quarter 2009 Earnings Release and Conference Call Schedule

10 July 2009
PR Newswire (US)

EU Clears SGL Carbon, Brembo Car Brake Joint Venture

The European Commission Thursday cleared German manufacturer of carbon products SGL Carbon SE (SGL.XE) and Italian car brakes maker Brembo SpA (BRE.MI) to create a joint venture producing carbon...

28 May 2009
Dow Jones News

BRE Properties Announces First Quarter 2009 Conference Call Webcast

SAN FRANCISCO, May 5 /PRNewswire-FirstCall/ -- BRE PROPERTIES, INC. (NYSE: BRE) announces the following Webcast: What: BRE Properties First Quarter 2009 Conference Call When: Wednesday...

06 May 2009
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.34-3.789145213428.9738.9998.5194127068.81496206DE
4-1.567-15.36274509810.210.3368.5195922629.39589611DE
12-1.735-16.734182098810.36810.6268.5196104039.7956722DE
26-2.217-20.433179723510.8511.1668.51948721810.07536189DE
52-2.087-19.468283582110.7212.398.51946804710.71768021DE
156-3.267-27.453781512611.915.198.00539206811.28732815DE
260-1.897-18.015194681910.5315.195.9148853810.33873437DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
1SNOWSnowflake Inc
166.00 €
(35.09%)
4.98k
WGML25GM Leather spa
0.013 €
(30.00%)
3k
WSAC25Saccheria Flli Franceschetti SpA
0.032 €
(28.00%)
1,000
WSGC28SG Company SpA
0.0259 €
(16.14%)
80k
WPAL26Palingeo SpA
0.3245 €
(15.89%)
61.9k
E9IAENovia spa
2.18 €
(-66.20%)
700
WABC27Abc Company Spa
0.013 €
(-55.17%)
4.5k
WAAT26AA Tech SpA
0.0231 €
(-23.00%)
29.49k
WS3D25Solid World Group spa
0.139 €
(-20.07%)
66.01k
1DTRHDaimler Truck Holding AG
35.90 €
(-13.81%)
2.84k
TITTelecom Italia SpA
0.2299 €
(-1.67%)
157.69M
ISPIntesa Sanpaolo Spa
3.6595 €
(-1.00%)
69.94M
SPMSaipem Spa
2.371 €
(1.89%)
31.09M
EPHEPH SpA
0.0002 €
(0.00%)
26.66M
ENELEnel Spa
6.58 €
(0.24%)
18.16M

Discussion

View Full Feed
manibiotech manibiotech 3 minutes ago
However the data of current trial submitted for approval is not "in vitro"
NWBO
payupdeadbeat payupdeadbeat 3 minutes ago
It is clear that the "investment of a lifetime* message is not getting out. I hope the longs are not being hornscwaggled.
ZHUD
Craig305 Craig305 4 minutes ago
This is the highest day volume since June 2022. 
AVVH
Serpico2005 Serpico2005 4 minutes ago
HUGE revenue pouring in here, we won't be denied, won't be able the hold it down much longer. 
SPZI
delerious1 delerious1 4 minutes ago
Milling results soon yet some say that this stock is garbage etc have been here as long as me or longer so that would mean plenty of time to see the patterns and make some really good money....but I bet that they haven't....so it is a bit of a conundrum....why wouldn't they when obviously given the
NBRI
ExtremelyBullishZig ExtremelyBullishZig 4 minutes ago
No...all biotechs are up based on gene editing company success it move the index 
AVXL
richme richme 4 minutes ago
Need to Curb Your Enthusiasm just because the share price jumped all the way to $0.0166 share price,
-$0.0015 day change. Isn't that great? We will be heading to Mars soon....no less in Elon Musk's rocket ship or to hell in ________ (add your own).
ZHUD
Quintessence Quintessence 4 minutes ago
PDYNW - Nice move today! I will consider buying dips.
JRoon71 JRoon71 4 minutes ago
TC, I get that. I just meant that in looking at what Italy pays for other drugs, what Amarin wants for Vazkepa is substantially more than MOST drugs on the list.

I'm not talking about the cost to patients, but the cost to the government.

If Vazkepa cost $15 to sell to
AMRN
dennisdave dennisdave 5 minutes ago
BTW, the three companies with approved PD1 inhibitors, which is what the U.S. patent office tried to narrow the combo patent to, are:

Merck = Keytruda

Opdivo = Bristol

Libtayo = Regeneron.
Thanks very helpful.
NWBO
attilathehunt attilathehunt 5 minutes ago
1 buy of 20k will work the same as 2 buys of 10k on squeeze day, no?

NO!!!!!

On squeeze day your first buy order will be much much lower than all subsequent ones...

For example, on Squeeze day (approval) if your first early open trade gets executed at 1.0
NWBO
bgATL bgATL 5 minutes ago
Gaetz is out, my opinion has been he was never really going to be in the position, as it was cover to let him resign from the House before the severe reprimands which could have ruined his chances of a future career. Trump also could now argue he tried to put a pot friendly guy in the office and it
TCNNF
Pic Pic 5 minutes ago
I wonder if .0011 is a good entry? Fishing time. 🎣
AFFU
konshe konshe 5 minutes ago
Strong buy at ask 0.0002, paint sell at bid 0.0001. 0.0002 2mm shares will be gone soon.
TPTW
al44 al44 5 minutes ago
The world will become safer when the ‘adults in the room’ are… gone

By Jack Hellner


When Biden and his team of incompetents took over, the media cheered that finally the adults were back in the room; well thankfully, the “children” will be back soon and the U.S.
Real McCoy Real McCoy 6 minutes ago
I think they think that announced participation in a hot industry segment should entitle them to valuation levels of those hot industry segment leaders. Despite ALWAYS having virtually no revenue.
VERB
KRISGO KRISGO 6 minutes ago
Hello Dcaf7, based on the full abstract being released on Nov 25th, can the experts evaluate whether same-day dosing is effective and works better?
ASRT
PennyMillions852 PennyMillions852 6 minutes ago
BID building here but...you KNOW what will come next......this is the type of chit that needs to stop for us to move up above .0003!
THBD
Hitman970 Hitman970 6 minutes ago
Why hasn't this historic moment made any mainstream press?
x / twitter and company generate PRs mean nothing.
You are repeating yourself over and over. Do you know Vic? You called him "benign" a while back.
BNCM
CrashOverride CrashOverride 6 minutes ago
If it was DCVax the 2016 paper would cite Liau or Prins as they are the leaders in the field of Dendritic-cell-based vaccines.

They had several papers published before 2016.

It doesn't so it isn't DCVax.
NWBO
biotechinvestor1 biotechinvestor1 6 minutes ago
From another poster: “Evotec has already said no thanks. Wall Street said no thanks. When Halozyme management says ok forget about it, we go up $10. We are waiting Ms Helen.”
HALO
BamaBreeze BamaBreeze 6 minutes ago
Can you bring in the update your referencing(please).
BLLB
redspinelpinktopaz redspinelpinktopaz 6 minutes ago
No. It seems all right to me.
LWLG
glenn1919 glenn1919 6 minutes ago
TRNR....CISO....MULN.........................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=2&dy=12&id=p84071410134
CISO MULN TRNR
WinstonCup WinstonCup 6 minutes ago
Sometimes you make no sense.
WDLF

Your Recent History

BIT
BRE
Brembo NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved